Drug intelligence / Profile preview

Fengshi Liquid

Development stage: Unknown
Lead developer: Tianjin Darentang Jingwanhong Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Fengshi Liquid (风湿液) is a traditional Chinese medicine (TCM) oral liquid developed and manufactured by Tianjin Darrentang Jingwanhong Pharmaceutical Co., Ltd. for the treatment of rheumatism. As a traditional herbal preparation, it is formulated according to TCM principles to alleviate symptoms associated with rheumatic conditions. The product is an approved marketed drug in China, identified by a national drug approval number (国药准字). While its specific molecular targets are not publicly detailed in standard pharmaceutical databases, it is part of a portfolio of traditional formulations from a company with historical ties to the Beijing Tongrentang heritage.

Brand names: Fengshi Liquid
Other names: Fengshi Ye风湿液

Beyond the preview

Go deeper on Fengshi Liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fengshi Liquid.

Explore the full profile